(1R,2S,3S,4R,8S,9S,11R)-11-hydroxy-4,8-dimethyl-12-methylidenetetracyclo[9.2.2.01,9.03,8]pentadecane-2,4-dicarboxylic acid
Internal ID | 074efc13-77f0-4fb2-bc27-ab74e0b91fde |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Dicarboxylic acids and derivatives |
IUPAC Name | (1R,2S,3S,4R,8S,9S,11R)-11-hydroxy-4,8-dimethyl-12-methylidenetetracyclo[9.2.2.01,9.03,8]pentadecane-2,4-dicarboxylic acid |
SMILES (Canonical) | CC12CCCC(C1C(C34C2CC(CC3)(C(=C)C4)O)C(=O)O)(C)C(=O)O |
SMILES (Isomeric) | C[C@@]12CCC[C@@]([C@H]1[C@@H]([C@]34[C@H]2C[C@](CC3)(C(=C)C4)O)C(=O)O)(C)C(=O)O |
InChI | InChI=1S/C20H28O5/c1-11-9-19-7-8-20(11,25)10-12(19)17(2)5-4-6-18(3,16(23)24)14(17)13(19)15(21)22/h12-14,25H,1,4-10H2,2-3H3,(H,21,22)(H,23,24)/t12-,13+,14-,17-,18+,19+,20+/m0/s1 |
InChI Key | HXWVTJWDIUTHPK-BGEPGUJHSA-N |
Popularity | 0 references in papers |
Molecular Formula | C20H28O5 |
Molecular Weight | 348.40 g/mol |
Exact Mass | 348.19367399 g/mol |
Topological Polar Surface Area (TPSA) | 94.80 Ų |
XlogP | 2.20 |
Atomic LogP (AlogP) | 3.08 |
H-Bond Acceptor | 3 |
H-Bond Donor | 3 |
Rotatable Bonds | 2 |
There are no found synonyms. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9894 | 98.94% |
Caco-2 | + | 0.5959 | 59.59% |
Blood Brain Barrier | + | 0.6750 | 67.50% |
Human oral bioavailability | + | 0.5429 | 54.29% |
Subcellular localzation | Mitochondria | 0.8380 | 83.80% |
OATP2B1 inhibitior | - | 0.8555 | 85.55% |
OATP1B1 inhibitior | + | 0.8930 | 89.30% |
OATP1B3 inhibitior | - | 0.3526 | 35.26% |
MATE1 inhibitior | - | 0.9600 | 96.00% |
OCT2 inhibitior | - | 0.5419 | 54.19% |
BSEP inhibitior | - | 0.9321 | 93.21% |
P-glycoprotein inhibitior | - | 0.8854 | 88.54% |
P-glycoprotein substrate | - | 0.8303 | 83.03% |
CYP3A4 substrate | + | 0.5823 | 58.23% |
CYP2C9 substrate | - | 0.5999 | 59.99% |
CYP2D6 substrate | - | 0.8675 | 86.75% |
CYP3A4 inhibition | - | 0.8447 | 84.47% |
CYP2C9 inhibition | - | 0.9600 | 96.00% |
CYP2C19 inhibition | - | 0.9713 | 97.13% |
CYP2D6 inhibition | - | 0.9495 | 94.95% |
CYP1A2 inhibition | - | 0.9217 | 92.17% |
CYP2C8 inhibition | - | 0.8281 | 82.81% |
CYP inhibitory promiscuity | - | 0.9590 | 95.90% |
UGT catelyzed | - | 0.6638 | 66.38% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.6095 | 60.95% |
Eye corrosion | - | 0.9951 | 99.51% |
Eye irritation | - | 0.7588 | 75.88% |
Skin irritation | + | 0.6785 | 67.85% |
Skin corrosion | - | 0.9375 | 93.75% |
Ames mutagenesis | - | 0.7300 | 73.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.5825 | 58.25% |
Micronuclear | - | 0.7300 | 73.00% |
Hepatotoxicity | - | 0.5125 | 51.25% |
skin sensitisation | - | 0.6477 | 64.77% |
Respiratory toxicity | - | 0.5778 | 57.78% |
Reproductive toxicity | + | 0.9667 | 96.67% |
Mitochondrial toxicity | + | 0.9750 | 97.50% |
Nephrotoxicity | + | 0.5000 | 50.00% |
Acute Oral Toxicity (c) | III | 0.5557 | 55.57% |
Estrogen receptor binding | + | 0.7520 | 75.20% |
Androgen receptor binding | + | 0.5378 | 53.78% |
Thyroid receptor binding | + | 0.6172 | 61.72% |
Glucocorticoid receptor binding | + | 0.7267 | 72.67% |
Aromatase binding | + | 0.6062 | 60.62% |
PPAR gamma | - | 0.5735 | 57.35% |
Honey bee toxicity | - | 0.9131 | 91.31% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | - | 0.6100 | 61.00% |
Fish aquatic toxicity | + | 1.0000 | 100.00% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.62% | 94.45% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 90.16% | 97.25% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 88.22% | 96.09% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.21% | 95.56% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.79% | 100.00% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.25% | 95.50% |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 80.69% | 96.38% |
PubChem | 162975450 |
LOTUS | LTS0044756 |
wikiData | Q105035181 |